All Perspectives

In response to public feedback to the initial terms of the Main Street Lending Program, the Federal Reserve Board announced on April 30, 2020, an expansion of the loan options available to businesses and an increase in the maximum size of businesses that are eligible to borrow under the Program.

What one hand giveth, the other can taketh away. That adage comes to mind when reviewing FDA’s most recent action with respect to the importation and distribution of KN95 and other respirator masks manufactured in China. 

On April 30, 2020, a group of Republican senators announced plans to introduce a federal privacy law called the “COVID-19 Consumer Data Protection Act of 2020” (CCDPA)[1].  Senator Wicker, who led the group of senators, has previously advocated for a federal privacy law.[2]

On May 5, 2020, the Council of the District of Columbia unanimously approved another bill in response to the ongoing COVID-19 crisis, the Coronavirus Omnibus Emergency Amendment Act of 2020. 

On May 3, 2020, the SBA and the US Department of the Treasury released new guidance to assist businesses with calculating the forgiveness amount for Paycheck Protection Program (PPP) loans, with respect to employees who reject an offer to be rehired by a PPP borrower.

The presence in the blood of antibodies specific to the novel coronavirus may help identify those who were unknowingly exposed to the virus but remained asymptomatic, those who were symptomatic but have fully recovered, and, as a result, those who might now have immunity, at least temporarily. Howev

The Federal Reserve continues to roll out multiple measures to strengthen the economy during the COVID-19 pandemic. Many of these measures are intended to buffer the housing market, which is affected by broader macroeconomic trends.

Earlier today, the Equal Employment Opportunity Commission (EEOC) posted an updated and expanded technical assistance publication addressing questions arising under the Federal Equal Employment Opportunity Laws related to the COVID-19 pandemic.  

Arent Fox Partner Kay Georgi will speak at the European Association of Trade and Investment Controls and Compliance Attorneys’ [AT+ICA] webinar titled “The Impact of New Export Controls on International Supply Chains.”

Partner Anne Murphy authored an article for The Governance Institute titled “The Governing Board’s Role in Assessing Possible Hospital Closure or Downsizing.”

American Bankers Association

Businesses across the country are facing challenges, including lawsuits, as they grapple with how COVID-19 has impacted their operations, work forces, and supply chains. The wave of litigation is rising, and it appears that no industry is immune.

As the fallout from the COVID-19 pandemic continues across the nation, consumers and businesses alike are resorting to class action litigation to air their grievances.

Below are six reimbursement issues that health care providers should be on “high alert” for as the COVID-19 crisis persists.

In the wake of the coronavirus, businesses and courts remain shuttered as a result of stay-at-home government orders.

In a first of its kind event, on May 4, 2020, the Supreme Court heard arguments-by-telephone, complete with apparent unintentional uses of the mute button, a pitfall many Americans can relate to as of late.

On May 4, 2020, the FDA issued new Guidance that drastically changes the requirements for serology/antibody tests for the COVID-19 epidemic.

On May 4, California Department of Consumer Affairs issued another order waiving additional requirements for pre-licensure nursing programs and nursing students under Title 16 of the California Code of Regulations (Code).

Partner J. Michael Showalter was quoted on President Trump’s executive order that asserted some agencies’ enforcement actions and adjudications could undermine the Administrative Procedure Act’s accountability and fairness goals.

Schiff Hardin is pleased to announce that three Intellectual Property Practice Group attorneys have been recognized as IP Stars in Illinois for 2020 by Managing Intellectual Property.

In its most recent effort to mitigate adverse effects of the COVID-19 pandemic on U.S. securities markets and to ease issuers’ access to capital, the NASDAQ Stock Market implemented a temporary exception from its shareholder approval requirements through June 30, 2020, effective immediately.

With the clean beauty movement on the rise, the Federal Trade Commission (FTC) has started to pay closer attention to how companies label and market personal care products.

Revised term sheets and FAQs issued by the Federal Reserve Board expand the program and provide additional guidance for borrowers affected by the COVID-19 crisis. A chart outlining the updated term sheets can be found in the link below.

As government officials begin to discuss reopening the economy, apparel brands should think about what preventative measures need to be implemented prior to reopening their retail locations across the country.

Schiff Hardin LLP represented Altaris Capital Partners LLC, a private investment firm focused on the healthcare industry, in its $650 million acquisition of substantially all of Kindeva Drug Delivery from 3M Company.